Pharmaceutical Wholesaling in the UK - Market Research Report 2015-2030

Steady Medicine: Industry Revenue is Expected to Remain Flat In 2022-23, Following a Fall In Revenue the Year Prior

The extreme change characterises the pharmaceutical and healthcare supply chain. The loss of patent protection for several high-profile drugs has hampered performance because it has lowered revenue generated from such medications. Increasingly stringent regulation has encouraged greater consumption of generic medicines and intensified downward pricing pressures. Regulatory and funding challenges threaten wholesalers, favouring the retail of low-price generic drugs instead of high-end branded varieties.

This industry covers businesses that wholesale pharmaceuticals or medical goods. These are distributed to pharmacies, specialist retailers, hospitals, doctors and other expert medical practitioners.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.